Literature DB >> 21474997

Polo-like kinase 1 regulates activation of AMP-activated protein kinase (AMPK) at the mitotic apparatus.

Alejandro Vazquez-Martin1, Cristina Oliveras-Ferraros, Sílvia Cufí, Javier A Menendez.   

Abstract

AMP-activated protein kinase (AMPK) is being primarily studied as a central metabolic stress sensor, which regulates cell survival and growth-related metabolic pathways to preserve intracellular ATP levels in response to energy deprivation. Evidence is now accumulating that AMPK plays also an obligatory role to ensure proper cell division and faithful chromosomal segregation during mitosis. Increased phosphorylation in the AMPK catalytic subunit (AMPKα) was found in a proteomic study for kinases activated during G2/M and, more recently, activated AMPKα (PP-AMPKα(Thr172)) has been observed to transiently associate with several mitotic structures including centrosomes, spindle poles, the central spindle midzone and the midbody throughout all of the mitotic stages and cytokinesis. How AMPKα activation is controlled spatially and temporally during mitosis, however, remained undiscovered. Because Polo-like Kinases (PLKs) regulate many aspects of mitotic progression including centrosome maturation, bipolar spindle assembly, chromosome congression & segregation, and cytokinesis, we decided to combine an immunofluorescence microscopy analysis with a chemical biology approach employing a small-molecule PLK1 inhibitor to dissect a putative relationship between PLK1 and AMPKα during G2/M transition. PLK1 and PP-AMPKα(Thr172) were found to display a major spatio-temporal overlap early at centrosomes, from prophase until anaphase, and late at the midbody, during telophase and cytokinesis. Moreover, short-term treatment with the thiophene derivative GW843682X, a selective PLK inhibitor that has 400-fold greater potency for PLK1 than for PLK2 or PLK3, fully abolished mitotic activation of AMPKα. Upon long-term PLK1 inhibition, PP-AMPKα(Thr172) was barely detected surrounding the spindle poles of prometaphase-like arrested cells displaying the "polo" phenotype. Similarly, PP-AMPKα(Thr172) was largely inhibited in GW843682X-treated cells exhibiting cytokinesis failure and binucleate cell formation. Given that PLK1 is a well-recognized master regulatory kinase for the numerous protein substrates involved in mitosis, our current description of a causal link between PLK1 activity and mitotic phosphorylation of AMPKα may provide fundamental insights into how the energy sensor AMPK is directly coupled to mitotic cell division and cell cycle exist.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21474997     DOI: 10.4161/cc.10.8.15342

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  28 in total

1.  Chemical genetic screen for AMPKα2 substrates uncovers a network of proteins involved in mitosis.

Authors:  Max R Banko; Jasmina J Allen; Bethany E Schaffer; Erik W Wilker; Peiling Tsou; Jamie L White; Judit Villén; Beatrice Wang; Sara R Kim; Kei Sakamoto; Steven P Gygi; Lewis C Cantley; Michael B Yaffe; Kevan M Shokat; Anne Brunet
Journal:  Mol Cell       Date:  2011-12-01       Impact factor: 17.970

2.  Nek9 regulates spindle organization and cell cycle progression during mouse oocyte meiosis and its location in early embryo mitosis.

Authors:  Shang-Wu Yang; Chen Gao; Lei Chen; Ya-Li Song; Jin-Liang Zhu; Shu-Tao Qi; Zong-Zhe Jiang; Zhong-Wei Wang; Fei Lin; Hao Huang; Fu-Qi Xing; Qing-Yuan Sun
Journal:  Cell Cycle       Date:  2012-11-16       Impact factor: 4.534

3.  Serine79-phosphorylated acetyl-CoA carboxylase, a downstream target of AMPK, localizes to the mitotic spindle poles and the cytokinesis furrow.

Authors:  Alejandro Vazquez-Martin; Bruna Corominas-Faja; Cristina Oliveras-Ferraros; Sílvia Cufí; Nicole Dalla Venezia; Javier A Menendez
Journal:  Cell Cycle       Date:  2013-04-19       Impact factor: 4.534

4.  A guiding torch at the poles: the multiple roles of spindle microtubule-organizing centers during cell division.

Authors:  Ana M Rincón; Fernando Monje-Casas
Journal:  Cell Cycle       Date:  2020-05-13       Impact factor: 4.534

5.  AMPK regulates mitotic spindle orientation through phosphorylation of myosin regulatory light chain.

Authors:  Jose T Thaiparambil; Carrie M Eggers; Adam I Marcus
Journal:  Mol Cell Biol       Date:  2012-06-11       Impact factor: 4.272

6.  Cyclin-dependent kinase 1-mediated AMPK phosphorylation regulates chromosome alignment and mitotic progression.

Authors:  Seth Stauffer; Yongji Zeng; Montserrat Santos; Jiuli Zhou; Yuanhong Chen; Jixin Dong
Journal:  J Cell Sci       Date:  2019-10-28       Impact factor: 5.285

7.  Ser2481-autophosphorylated mTOR colocalizes with chromosomal passenger proteins during mammalian cell cytokinesis.

Authors:  Alejandro Vazquez-Martin; Tamara Sauri-Nadal; Octavio J Menendez; Cristina Oliveras-Ferraros; Sílvia Cufí; Bruna Corominas-Faja; Eugeni López-Bonet; Javier A Menendez
Journal:  Cell Cycle       Date:  2012-10-24       Impact factor: 4.534

8.  Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells.

Authors:  Guojun Zhang; Zhe Zhang; Zhuogang Liu
Journal:  Tumour Biol       Date:  2013-03-14

9.  Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine.

Authors:  William H Chappell; Stephen L Abrams; Richard A Franklin; Michelle M LaHair; Giuseppe Montalto; Melchiorre Cervello; Alberto M Martelli; Ferdinando Nicoletti; Saverio Candido; Massimo Libra; Jerry Polesel; Renato Talamini; Michele Milella; Agostino Tafuri; Linda S Steelman; James A McCubrey
Journal:  Cell Cycle       Date:  2012-11-16       Impact factor: 4.534

10.  PLK1 inhibitors synergistically potentiate HDAC inhibitor lethality in imatinib mesylate-sensitive or -resistant BCR/ABL+ leukemia cells in vitro and in vivo.

Authors:  Girija Dasmahapatra; Hiral Patel; Tri Nguyen; Elisa Attkisson; Steven Grant
Journal:  Clin Cancer Res       Date:  2012-11-30       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.